Mallinckrodt Presents Data on Real-World Outcomes with Acthar® Gel (repository corticotropin injection) at the International Congress on Systemic Lupus Erythematosus (LUPUS 2025)

– Late-breaking poster abstract highlights physician-reported treatment patterns and characteristics of patients with systemic lupus erythematosus treated with Acthar Gel1 – DUBLIN, May 14, 2025 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced a...